Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy - Scorecard - MDSpire

Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

  • By

  • Fatimah Salem Alayidh

  • Alexander Woodman

  • Nawaf Yahya Zakary

  • Rehab Yusuf Al-Ansari

  • Sharjeel Chaudhry

  • Amal Omar Alsaadi

  • Khadijah Ahmad Alharbi

  • Batool Abdullah Alamri

  • Shahad Mousa Alhomud

  • Shahad Hassan Albather

  • Sarah Abdullah Bataweel

  • Nouf Ahmed Madkhali

  • Samira Jamaan Alzahrani

  • Zarmina Ehtesham

  • February 2, 2026

  • 0 min

Share

Clinical Scorecard: Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationAdults (age > 18 years) diagnosed with chronic HCV infection, including non-cirrhotic and compensated cirrhotic patients; minors were excluded.
Care Setting

Key Highlights

  • The study's retrospective nature provides insights into real-world treatment outcomes.

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider management strategies for patients with indeterminate genotypes.

    Monitoring & Follow-up

      Risks

        Patient & Prescribing Data

        DAAs have shown high efficacy and tolerability, with a significant proportion achieving SVR; demographic factors may influence outcomes.

        Clinical Best Practices

        • Implement follow-up strategies for patients who do not achieve SVR.

        References

        Original Source(s)

        Retrospective Analysis of Direct-Acting Antiviral Treatment Outcomes in Hepatitis C Patients in Saudi Arabia Before and After Therapy

        • by Fatimah Salem Alayidh, Alexander Woodman, Nawaf Yahya Zakary, Rehab Yusuf Al-Ansari, Sharjeel Chaudhry, Amal Omar Alsaadi, Khadijah Ahmad Alharbi, Batool Abdullah Alamri, Shahad Mousa Alhomud, Shahad Hassan Albather, Sarah Abdullah Bataweel, Nouf Ahmed Madkhali, Samira Jamaan Alzahrani, Zarmina Ehtesham

        • February 2, 2026

        Related Content

        Indiana community fights to keep needle exchange going after Trump order

        Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies

        Routine vs. Risk-Based Vaccination

        The CDC has dropped routine recommendations for six childhood vaccines, shifting decisions to parents and doctors despite decades of evidence showing the shots prevented millions of hospitalizations and tens of thousands of deaths.